| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 5.830 | 15.088 | 19.909 | 8.952 | 44.152 | 50.779 |
| Total Income - EUR | - | - | - | - | 5.830 | 15.088 | 19.909 | 8.952 | 44.152 | 50.779 |
| Total Expenses - EUR | - | - | - | - | 1.931 | 3.566 | 6.964 | 8.607 | 20.098 | 28.789 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.899 | 11.522 | 12.945 | 346 | 24.054 | 21.989 |
| Net Profit/Loss - EUR | - | - | - | - | 3.724 | 11.113 | 12.348 | 126 | 23.613 | 20.695 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oftasense Piatra-Neamţ S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 14.551 | 10.475 | 6.719 | 39.853 |
| Current Assets | - | - | - | - | 4.041 | 14.953 | 10.241 | 15.504 | 19.266 | 32.392 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 527 | 0 | 749 | 924 | 0 | 0 |
| Cash | - | - | - | - | 3.514 | 14.953 | 9.492 | 14.580 | 19.266 | 32.392 |
| Shareholders Funds | - | - | - | - | 3.766 | 14.808 | 24.700 | 24.903 | 22.510 | 43.079 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 274 | 144 | 92 | 1.076 | 3.474 | 29.165 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftasense Piatra-Neamţ S.r.l.